Literature DB >> 23583467

Acute kidney injury in patients with cirrhosis: perils and promise.

Justin M Belcher1, Chirag R Parikh, Guadalupe Garcia-Tsao.   

Abstract

A 62-year-old man with cirrhosis secondary to hepatitis C and chronic alcohol abuse was admitted to the intensive care unit with hematemesis and mental status changes. Physical examination showed ascites and stigmata of chronic liver disease. Blood pressure was noted as 87/42 mm Hg and laboratory studies showed a serum creatinine level of 0.8 mg/dL, an estimated glomerular filtration rate of 84 mL/min/1.73 m(2) calculated using the Modification of Diet in Renal Disease Study equation, a serum sodium level of 123 mEq/L, a total serum bilirubin level of 4.3 mg/dL, and an international normalization ratio of 1.6. The patient was resuscitated with packed red blood cells and fresh-frozen plasma and bleeding was controlled. However, on the third day of admission, creatinine level increased to 1.5 mg/dL. Examination of urine sediment showed 1 to 5 bilirubin-stained granular casts per high-powered field and a few renal tubular epithelial cells. The urine sodium level was 21 mEq/L and the fractional excretion of sodium was 0.43%.
Copyright © 2013 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AKI; AKIN; ATN; Acute Kidney Injury Network; Acute Tubular Necrosis; Ascites; CKD; Cirrhosis; FENa; GFR; HRS; Hepatorenal; IAC; ICU; International Ascites Club; KIM-1; Kidney Injury; MDRD; Modification of Diet in Renal Disease; NGAL; OR; PRA; RAAS; Urinary Biomarkers; acute kidney injury; acute tubular necrosis; chronic kidney disease; fractional excretion of sodium; glomerular filtration rate; hepatorenal syndrome; intensive care unit; kidney injury molecule-1; neutrophil gelatinase–associated lipocalin; odds ratio; prerenal azotemia; renin-angiotensin-aldosterone system

Mesh:

Substances:

Year:  2013        PMID: 23583467      PMCID: PMC3840046          DOI: 10.1016/j.cgh.2013.03.018

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  57 in total

1.  The new definition of acute kidney injury in patients with cirrhosis: a critical look.

Authors:  Carlos Noronha Ferreira; Teresa Rodrigues; Helena Cortez-Pinto; Fátima Serejo; Fernando Ramalho; Paula Alexandrino; José Velosa
Journal:  Gut       Date:  2012-01-27       Impact factor: 23.059

2.  Biomarkers predict progression of acute kidney injury after cardiac surgery.

Authors:  Jay L Koyner; Amit X Garg; Steven G Coca; Kyaw Sint; Heather Thiessen-Philbrook; Uptal D Patel; Michael G Shlipak; Chirag R Parikh
Journal:  J Am Soc Nephrol       Date:  2012-03-01       Impact factor: 10.121

3.  Difference between CKD-EPI and MDRD equations in calculating glomerular filtration rate in patients with cirrhosis.

Authors:  Yu-Wei Chen; Han-Hsiang Chen; Tsang-En Wang; Ching-Wei Chang; Chen-Wang Chang; Chih-Jen Wu
Journal:  World J Gastroenterol       Date:  2011-10-28       Impact factor: 5.742

4.  Clinical applications of biomarkers for acute kidney injury.

Authors:  Justin M Belcher; Charles L Edelstein; Chirag R Parikh
Journal:  Am J Kidney Dis       Date:  2011-03-15       Impact factor: 8.860

5.  Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis.

Authors:  Claudia Fagundes; Marie-Noëlle Pépin; Mónica Guevara; Rogelio Barreto; Gregori Casals; Elsa Solà; Gustavo Pereira; Ezequiel Rodríguez; Elisabet Garcia; Verónica Prado; Esteban Poch; Wladimiro Jiménez; Javier Fernández; Vicente Arroyo; Pere Ginès
Journal:  J Hepatol       Date:  2012-04-17       Impact factor: 25.083

Review 6.  Terlipressin in hepatorenal syndrome: a systematic review and meta-analysis.

Authors:  Mirela Dobre; Sevag Demirjian; Ashwini R Sehgal; Sankar D Navaneethan
Journal:  Int Urol Nephrol       Date:  2010-03-20       Impact factor: 2.370

7.  Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure.

Authors:  Arash Aghel; Kevin Shrestha; Wilfried Mullens; Allen Borowski; W H Wilson Tang
Journal:  J Card Fail       Date:  2009-08-21       Impact factor: 5.712

8.  Variceal hemorrhage: Saudi tertiary center experience of clinical presentations, complications and mortality.

Authors:  Hind I Fallatah; Haifaa Al Nahdi; Maan Al Khatabi; Hisham O Akbar; Yousif A Qari; Abdul Rahman Sibiani; Salim Bazaraa
Journal:  World J Hepatol       Date:  2012-09-27

9.  LEFT ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction.

Authors:  André Nazar; Mónica Guevara; Marta Sitges; Carlos Terra; Elsa Solà; Carina Guigou; Vicente Arroyo; Pere Ginès
Journal:  J Hepatol       Date:  2012-09-16       Impact factor: 25.083

10.  Relationship between activation of the sympathetic nervous system and renal blood flow autoregulation in cirrhosis.

Authors:  Vanessa Stadlbauer; Vanessa P Stadlbauer; Gavin A K Wright; Murad Banaji; Ashis Mukhopadhya; Rajeshwar P Mookerjee; Rajeshwar Mookerjee; Kevin Moore; Rajiv Jalan
Journal:  Gastroenterology       Date:  2008-01       Impact factor: 22.682

View more
  25 in total

1.  The Use of Selected Urine Chemistries in the Diagnosis of Kidney Disorders.

Authors:  Biff F Palmer; Deborah Joy Clegg
Journal:  Clin J Am Soc Nephrol       Date:  2019-01-09       Impact factor: 8.237

2.  Beneficial and harmful effects of nonselective beta blockade on acute kidney injury in liver transplant candidates.

Authors:  Sang Gyune Kim; Joseph J Larson; Ji Sung Lee; Terry M Therneau; W Ray Kim
Journal:  Liver Transpl       Date:  2017-06       Impact factor: 5.799

Review 3.  Acute kidney injury in acute on chronic liver failure.

Authors:  Rakhi Maiwall; S K Sarin; Richard Moreau
Journal:  Hepatol Int       Date:  2015-10-15       Impact factor: 6.047

Review 4.  Urine biochemistry assessment in critically ill patients: controversies and future perspectives.

Authors:  Alexandre Toledo Maciel; Daniel Vitorio
Journal:  J Clin Monit Comput       Date:  2016-04-01       Impact factor: 2.502

Review 5.  Immunologic, hemodynamic, and adrenal incompetence in cirrhosis: impact on renal dysfunction.

Authors:  Louise Madeleine Risør; Flemming Bendtsen; Søren Møller
Journal:  Hepatol Int       Date:  2014-09-27       Impact factor: 6.047

Review 6.  Cirrhotic Multiorgan Syndrome.

Authors:  Søren Møller; Flemming Bendtsen
Journal:  Dig Dis Sci       Date:  2015-06-26       Impact factor: 3.199

Review 7.  Renal dysfunction in cirrhosis.

Authors:  Nathalie H Urrunaga; Ayse L Mindikoglu; Don C Rockey
Journal:  Curr Opin Gastroenterol       Date:  2015-05       Impact factor: 3.287

8.  AKI in patients with acute on chronic liver failure is different from acute decompensation of cirrhosis.

Authors:  Rakhi Maiwall; Suman Kumar; Shivendra Singh Chandel; Guresh Kumar; Archana Rastogi; Chhagan Bihari; Manoj Kumar Sharma; Bhaskar Thakur; K Jamwal; Suman Nayak; R P Mathur; S K Sarin
Journal:  Hepatol Int       Date:  2015-09-02       Impact factor: 6.047

9.  Changes in Kidney Function After Transjugular Intrahepatic Portosystemic Shunts Versus Large-Volume Paracentesis in Cirrhosis: A Matched Cohort Analysis.

Authors:  Andrew S Allegretti; Guillermo Ortiz; Jie Cui; Julia Wenger; Ishir Bhan; Raymond T Chung; Ravi I Thadhani; Zubin Irani
Journal:  Am J Kidney Dis       Date:  2016-03-16       Impact factor: 8.860

10.  Renal failure in cirrhosis: is it time to change the diagnosis and classification?

Authors:  Suthat Liangpunsakul; Rajiv Agarwal
Journal:  Am J Nephrol       Date:  2013-10-05       Impact factor: 3.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.